(R)-Nifuratel is disclosed together with its use as bactericide and bacteriostatic agent as well as the pharmaceutical compositions containing the same; (R)- nifuratel has been surprisingly found to possess a better antimicrobial profile than either nifuratel racemate or (S)-nifuratel. A new procedure for the synthesis of both (R)-Nifuratel and (S)-Nifuratel is also disclosed.
(R)-尼
氟噻唑已经公开,以及作为杀菌剂和抑菌剂的用途,以及含有该化合物的药物组合物;令人惊讶地发现,(R)-尼
氟噻唑具有比尼
氟噻唑外消旋体或(S)-尼
氟噻唑更好的抗微
生物特性。同时还公开了一种合成(R)-尼
氟噻唑和(S)-尼
氟噻唑的新方法。